Specifically, the analysis of mRNAs-lncRNAs networks in glioblastoma tissue-derived CD133+/Nestin CSCs and their differentiated derivatives revealed three pairs of lncRNAs and their targeted mRNAs that may critically affect CSC differentiation [99]. The gene discussed is PROM1; the disease is glioblastoma.